PELP1: A Novel Therapeutic Target for Hormonal Cancers

被引：27
|
作者：
Chakravarty, Dimple [1 ]
Tekmal, Rajeshwar Rao [1 ]
Vadlamudi, Ratna K. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA
来源：
IUBMB LIFE | 2010年 / 62卷 / 03期
关键词：
estrogen receptor; coregulators; PELP1; hormonal signaling; therapy resistance; GLUTAMIC-ACID-RICH; RECEPTOR COACTIVATOR PELP1/MNAR; GROWTH-FACTOR REGULATION; RETRACTED ARTICLE. SEE; ESTROGEN-RECEPTOR; BREAST-CANCER; PROLINE-RICH; NONGENOMIC ACTIVITY; INTERACTING PROTEIN; COREGULATOR PELP1;
D O I：
10.1002/iub.287
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Recent studies implicate that the estrogen receptor (ER) coregulator proline-, glutamic acid-, and leucine-rich protein (PELP) 1 as playing critical roles in ER-genomic, ER-nongenomic, and ER-signaling cross talk with growth factor signaling pathways. PELP1 expression is deregulated in hormonal cancers and recent studies further elucidated the molecular mechanisms by which PELP1 regulates hormone therapy response. Although PELP1 is important for normal functions of the ER, the possibility to target ER-PELP1 axis appears to be an effective strategy for preventing hormonal carcinogenesis and therapy resistance. Thus, PELP1 may be useful as prognostic marker for hormonal cancers and PELP1 signaling may be useful to generate targeted therapeutics to overcome hormonal therapy resistance. (C) 2009 IUBMB IUBMB Life, 62(3): 163-169, 2010
引用
收藏
页码：163 / 169
页数：7
相关论文
共 50 条
  • [41] Cancer Stem Cell Phenotypes in ERthorn Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes
    Truong, Thu H.
    Hu, Hsiangyu
    Temiz, Nuri A.
    Hagen, Kyla M.
    Girard, Brian J.
    Brady, Nicholas J.
    Schwertfeger, Kathryn L.
    Lange, Carol A.
    Ostrander, Julie H.
    MOLECULAR CANCER RESEARCH, 2018, 16 (04) : 707 - 719
  • [42] PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis
    Yang, Xue
    Liu, Zexuan
    Tang, Weiwei
    Pratap, Uday P.
    Collier, Alexia B.
    Altwegg, Kristin A.
    Gopalam, Rahul
    Li, Xiaonan
    Yuan, Yaxia
    Zhou, Daohong
    Lai, Zhao
    Chen, Yidong
    Sareddy, Gangadhara R.
    Valente, Philip T.
    Kost, Edward R.
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna K.
    MOLECULAR ONCOLOGY, 2024, 18 (09) : 2136 - 2156
  • [43] Increased PELP1 expression in rat periodontal ligament tissue in response to estrogens treatment
    Wang, Jing
    Zhu, Qiang
    Song, Shujun
    Dong, Jun
    Shi, Lixin
    Tao, Ran
    Ding, Yin
    Hong, Baofa
    JOURNAL OF MOLECULAR HISTOLOGY, 2013, 44 (03) : 347 - 356
  • [44] Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis
    Kefalopoulou, Zinovia
    Tzelepi, Vassiliki
    Zolota, Vassiliki
    Grivas, Petros D.
    Christopoulos, Christos
    Kalofonos, Haralabos
    Maraziotis, Theodoros
    Sotiropoulou-Bonikou, Georgia
    JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (01) : 23 - 31
  • [45] Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
    Altwegg, Kristin A.
    Pratap, Uday P.
    Liu, Zexuan
    Liu, Junhao
    Sanchez, John R.
    Yang, Xue
    Ebrahimi, Behnam
    Panneerdoss, Durga Meenakshi
    Li, Xiaonan
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Rao, Manjeet K.
    Vadlamudi, Ratna K.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (01) : 151 - 162
  • [46] Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation
    Englert-Golon, Monika
    Andrusiewicz, Miroslaw
    Zbikowska, Aleksandra
    Chmielewska, Malgorzata
    Sajdak, Stefan
    Kotwicka, Malgorzata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [47] Hormonal receptor determination of 1,052 Chinese breast cancers
    Chow, LWC
    Ho, P
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (03) : 172 - 175
  • [48] Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases
    Zhang, Yanzhi
    Dai, Jiali
    McNamara, Keely M.
    Bai, Bing
    Shi, Mumu
    Chan, Monica S. M.
    Liu, Ming
    Sasano, Hironobu
    Wang, Xiuli
    Li, Xiaolei
    Liu, Lijuan
    Ma, Ying
    Cao, Shuwen
    Xing, Yanchun
    Zhao, Baoshan
    Song, Yinli
    Wang, Lin
    BMC CANCER, 2015, 15
  • [49] The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
    Aust, Stefanie
    Horak, Peter
    Pils, Dietmar
    Pils, Sophie
    Grimm, Christoph
    Horvat, Reinhard
    Tong, Dan
    Schmid, Bernd
    Speiser, Paul
    Reinthaller, Alexander
    Polterauer, Stephan
    BMC CANCER, 2013, 13
  • [50] Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
    Liu, Junhao
    Liu, Zexuan
    Li, Mengxing
    Tang, Weiwei
    Pratap, Uday P.
    Luo, Yiliao
    Altwegg, Kristin A.
    Li, Xiaonan
    Zou, Yi
    Zhu, Hong
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna K.
    MOLECULAR ONCOLOGY, 2021, 15 (04) : 1146 - 1161
12345